Genome-wide association study of Alzheimer's disease

M. I. Kamboh, F. Y. Demirci, X. Wang, R. L. Minster, M. M. Carrasquillo, V. S. Pankratz, S. G. Younkin, Andrew Saykin, G. Jun, C. Baldwin, M. W. Logue, J. Buros, L. Farrer, M. A. Pericak-Vance, J. L. Haines, R. A. Sweet, M. Ganguli, E. Feingold, S. T. Dekosky, O. L. Lopez & 1 others M. M. Barmada

Research output: Contribution to journalArticle

118 Citations (Scopus)

Abstract

In addition to apolipoprotein E (APOE), recent large genome-wide association studies (GWASs) have identified nine other genes/loci (CR1, BIN1, CLU, PICALM, MS4A4/MS4A6E, CD2AP, CD33, EPHA1 and ABCA7) for late-onset Alzheimer's disease (LOAD). However, the genetic effect attributable to known loci is about 50%, indicating that additional risk genes for LOAD remain to be identified. In this study, we have used a new GWAS data set from the University of Pittsburgh (1291 cases and 938 controls) to examine in detail the recently implicated nine new regions with Alzheimer's disease (AD) risk, and also performed a meta-analysis utilizing the top 1% GWAS single-nucleotide polymorphisms (SNPs) with P < 0.01 along with four independent data sets (2727 cases and 3336 controls) for these SNPs in an effort to identify new AD loci. The new GWAS data were generated on the Illumina Omni1-Quad chip and imputed at ∼2.5 million markers. As expected, several markers in the APOE regions showed genome-wide significant associations in the Pittsburg sample. While we observed nominal significant associations (P0.05) either within or adjacent to five genes (PICALM, BIN1, ABCA7, MS4A4/MS4A6E and EPHA1), significant signals were observed 69-180 kb outside of the remaining four genes (CD33, CLU, CD2AP and CR1). Meta-analysis on the top 1% SNPs revealed a suggestive novel association in the PPP1R3B gene (top SNP rs3848140 with P=3.05E-07). The association of this SNP with AD risk was consistent in all five samples with a meta-analysis odds ratio of 2.43. This is a potential candidate gene for AD as this is expressed in the brain and is involved in lipid metabolism. These findings need to be confirmed in additional samples.

Original languageEnglish
Article numbere117
JournalTranslational Psychiatry
Volume2
DOIs
StatePublished - 2012

Fingerprint

Genome-Wide Association Study
Alzheimer Disease
Single Nucleotide Polymorphism
Genes
Meta-Analysis
Apolipoproteins E
Lipid Metabolism
Odds Ratio
Genome
Brain

Keywords

  • Alzheimer's disease
  • genome-wide association study
  • meta-analysis
  • PPP1R3B
  • PTK2B
  • single-nucleotide polymorphisms

ASJC Scopus subject areas

  • Psychiatry and Mental health
  • Biological Psychiatry
  • Cellular and Molecular Neuroscience

Cite this

Kamboh, M. I., Demirci, F. Y., Wang, X., Minster, R. L., Carrasquillo, M. M., Pankratz, V. S., ... Barmada, M. M. (2012). Genome-wide association study of Alzheimer's disease. Translational Psychiatry, 2, [e117]. https://doi.org/10.1038/tp.2012.45

Genome-wide association study of Alzheimer's disease. / Kamboh, M. I.; Demirci, F. Y.; Wang, X.; Minster, R. L.; Carrasquillo, M. M.; Pankratz, V. S.; Younkin, S. G.; Saykin, Andrew; Jun, G.; Baldwin, C.; Logue, M. W.; Buros, J.; Farrer, L.; Pericak-Vance, M. A.; Haines, J. L.; Sweet, R. A.; Ganguli, M.; Feingold, E.; Dekosky, S. T.; Lopez, O. L.; Barmada, M. M.

In: Translational Psychiatry, Vol. 2, e117, 2012.

Research output: Contribution to journalArticle

Kamboh, MI, Demirci, FY, Wang, X, Minster, RL, Carrasquillo, MM, Pankratz, VS, Younkin, SG, Saykin, A, Jun, G, Baldwin, C, Logue, MW, Buros, J, Farrer, L, Pericak-Vance, MA, Haines, JL, Sweet, RA, Ganguli, M, Feingold, E, Dekosky, ST, Lopez, OL & Barmada, MM 2012, 'Genome-wide association study of Alzheimer's disease', Translational Psychiatry, vol. 2, e117. https://doi.org/10.1038/tp.2012.45
Kamboh MI, Demirci FY, Wang X, Minster RL, Carrasquillo MM, Pankratz VS et al. Genome-wide association study of Alzheimer's disease. Translational Psychiatry. 2012;2. e117. https://doi.org/10.1038/tp.2012.45
Kamboh, M. I. ; Demirci, F. Y. ; Wang, X. ; Minster, R. L. ; Carrasquillo, M. M. ; Pankratz, V. S. ; Younkin, S. G. ; Saykin, Andrew ; Jun, G. ; Baldwin, C. ; Logue, M. W. ; Buros, J. ; Farrer, L. ; Pericak-Vance, M. A. ; Haines, J. L. ; Sweet, R. A. ; Ganguli, M. ; Feingold, E. ; Dekosky, S. T. ; Lopez, O. L. ; Barmada, M. M. / Genome-wide association study of Alzheimer's disease. In: Translational Psychiatry. 2012 ; Vol. 2.
@article{ec92a131f7034a0398a6c365953acdd9,
title = "Genome-wide association study of Alzheimer's disease",
abstract = "In addition to apolipoprotein E (APOE), recent large genome-wide association studies (GWASs) have identified nine other genes/loci (CR1, BIN1, CLU, PICALM, MS4A4/MS4A6E, CD2AP, CD33, EPHA1 and ABCA7) for late-onset Alzheimer's disease (LOAD). However, the genetic effect attributable to known loci is about 50{\%}, indicating that additional risk genes for LOAD remain to be identified. In this study, we have used a new GWAS data set from the University of Pittsburgh (1291 cases and 938 controls) to examine in detail the recently implicated nine new regions with Alzheimer's disease (AD) risk, and also performed a meta-analysis utilizing the top 1{\%} GWAS single-nucleotide polymorphisms (SNPs) with P < 0.01 along with four independent data sets (2727 cases and 3336 controls) for these SNPs in an effort to identify new AD loci. The new GWAS data were generated on the Illumina Omni1-Quad chip and imputed at ∼2.5 million markers. As expected, several markers in the APOE regions showed genome-wide significant associations in the Pittsburg sample. While we observed nominal significant associations (P0.05) either within or adjacent to five genes (PICALM, BIN1, ABCA7, MS4A4/MS4A6E and EPHA1), significant signals were observed 69-180 kb outside of the remaining four genes (CD33, CLU, CD2AP and CR1). Meta-analysis on the top 1{\%} SNPs revealed a suggestive novel association in the PPP1R3B gene (top SNP rs3848140 with P=3.05E-07). The association of this SNP with AD risk was consistent in all five samples with a meta-analysis odds ratio of 2.43. This is a potential candidate gene for AD as this is expressed in the brain and is involved in lipid metabolism. These findings need to be confirmed in additional samples.",
keywords = "Alzheimer's disease, genome-wide association study, meta-analysis, PPP1R3B, PTK2B, single-nucleotide polymorphisms",
author = "Kamboh, {M. I.} and Demirci, {F. Y.} and X. Wang and Minster, {R. L.} and Carrasquillo, {M. M.} and Pankratz, {V. S.} and Younkin, {S. G.} and Andrew Saykin and G. Jun and C. Baldwin and Logue, {M. W.} and J. Buros and L. Farrer and Pericak-Vance, {M. A.} and Haines, {J. L.} and Sweet, {R. A.} and M. Ganguli and E. Feingold and Dekosky, {S. T.} and Lopez, {O. L.} and Barmada, {M. M.}",
year = "2012",
doi = "10.1038/tp.2012.45",
language = "English",
volume = "2",
journal = "Translational Psychiatry",
issn = "2158-3188",
publisher = "Nature Publishing Group",

}

TY - JOUR

T1 - Genome-wide association study of Alzheimer's disease

AU - Kamboh, M. I.

AU - Demirci, F. Y.

AU - Wang, X.

AU - Minster, R. L.

AU - Carrasquillo, M. M.

AU - Pankratz, V. S.

AU - Younkin, S. G.

AU - Saykin, Andrew

AU - Jun, G.

AU - Baldwin, C.

AU - Logue, M. W.

AU - Buros, J.

AU - Farrer, L.

AU - Pericak-Vance, M. A.

AU - Haines, J. L.

AU - Sweet, R. A.

AU - Ganguli, M.

AU - Feingold, E.

AU - Dekosky, S. T.

AU - Lopez, O. L.

AU - Barmada, M. M.

PY - 2012

Y1 - 2012

N2 - In addition to apolipoprotein E (APOE), recent large genome-wide association studies (GWASs) have identified nine other genes/loci (CR1, BIN1, CLU, PICALM, MS4A4/MS4A6E, CD2AP, CD33, EPHA1 and ABCA7) for late-onset Alzheimer's disease (LOAD). However, the genetic effect attributable to known loci is about 50%, indicating that additional risk genes for LOAD remain to be identified. In this study, we have used a new GWAS data set from the University of Pittsburgh (1291 cases and 938 controls) to examine in detail the recently implicated nine new regions with Alzheimer's disease (AD) risk, and also performed a meta-analysis utilizing the top 1% GWAS single-nucleotide polymorphisms (SNPs) with P < 0.01 along with four independent data sets (2727 cases and 3336 controls) for these SNPs in an effort to identify new AD loci. The new GWAS data were generated on the Illumina Omni1-Quad chip and imputed at ∼2.5 million markers. As expected, several markers in the APOE regions showed genome-wide significant associations in the Pittsburg sample. While we observed nominal significant associations (P0.05) either within or adjacent to five genes (PICALM, BIN1, ABCA7, MS4A4/MS4A6E and EPHA1), significant signals were observed 69-180 kb outside of the remaining four genes (CD33, CLU, CD2AP and CR1). Meta-analysis on the top 1% SNPs revealed a suggestive novel association in the PPP1R3B gene (top SNP rs3848140 with P=3.05E-07). The association of this SNP with AD risk was consistent in all five samples with a meta-analysis odds ratio of 2.43. This is a potential candidate gene for AD as this is expressed in the brain and is involved in lipid metabolism. These findings need to be confirmed in additional samples.

AB - In addition to apolipoprotein E (APOE), recent large genome-wide association studies (GWASs) have identified nine other genes/loci (CR1, BIN1, CLU, PICALM, MS4A4/MS4A6E, CD2AP, CD33, EPHA1 and ABCA7) for late-onset Alzheimer's disease (LOAD). However, the genetic effect attributable to known loci is about 50%, indicating that additional risk genes for LOAD remain to be identified. In this study, we have used a new GWAS data set from the University of Pittsburgh (1291 cases and 938 controls) to examine in detail the recently implicated nine new regions with Alzheimer's disease (AD) risk, and also performed a meta-analysis utilizing the top 1% GWAS single-nucleotide polymorphisms (SNPs) with P < 0.01 along with four independent data sets (2727 cases and 3336 controls) for these SNPs in an effort to identify new AD loci. The new GWAS data were generated on the Illumina Omni1-Quad chip and imputed at ∼2.5 million markers. As expected, several markers in the APOE regions showed genome-wide significant associations in the Pittsburg sample. While we observed nominal significant associations (P0.05) either within or adjacent to five genes (PICALM, BIN1, ABCA7, MS4A4/MS4A6E and EPHA1), significant signals were observed 69-180 kb outside of the remaining four genes (CD33, CLU, CD2AP and CR1). Meta-analysis on the top 1% SNPs revealed a suggestive novel association in the PPP1R3B gene (top SNP rs3848140 with P=3.05E-07). The association of this SNP with AD risk was consistent in all five samples with a meta-analysis odds ratio of 2.43. This is a potential candidate gene for AD as this is expressed in the brain and is involved in lipid metabolism. These findings need to be confirmed in additional samples.

KW - Alzheimer's disease

KW - genome-wide association study

KW - meta-analysis

KW - PPP1R3B

KW - PTK2B

KW - single-nucleotide polymorphisms

UR - http://www.scopus.com/inward/record.url?scp=84861318502&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84861318502&partnerID=8YFLogxK

U2 - 10.1038/tp.2012.45

DO - 10.1038/tp.2012.45

M3 - Article

VL - 2

JO - Translational Psychiatry

JF - Translational Psychiatry

SN - 2158-3188

M1 - e117

ER -